Clinical development of gene- and cell-based therapies: overview of the European landscape
暂无分享，去创建一个
[1] H. Guchelaar,et al. Development of cell therapy medicinal products by academic institutes. , 2016, Drug discovery today.
[2] H. Guchelaar,et al. Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation. , 2016, Cytotherapy.
[3] Yves Bayon,et al. Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products. , 2015, Tissue engineering. Part B, Reviews.
[4] I. Bisson,et al. Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives. , 2015, Regenerative medicine.
[5] E. Mischak-Weissinger,et al. Regulation of advanced therapy medicinal products in Europe and the role of academia. , 2013, Cytotherapy.
[6] Andrew Buchanan,et al. Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] A. Izeta,et al. Clinical translation of stem cell therapies: a bridgeable gap. , 2010, Cell stem cell.
[8] H. Eichler,et al. Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency , 2009, European Journal of Clinical Pharmacology.
[9] E. Flory,et al. European regulation tackles tissue engineering , 2007, Nature Biotechnology.